✦ LIBER ✦

Pramipexole for early Parkinson's disease? Yes and no, say US experts

✍ Scribed by Marilynn Larkin

Book ID: 117293562
Publisher: The Lancet
Year: 2000
Tongue: English
Weight: 57 KB
Volume: 356
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(05)74053-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cabergoline, Pramipexole and Ropinirole

Cabergoline, Pramipexole and Ropinirole Used as Monotherapy in Early Parkinson’s Disease

✍ Dr Rivka Inzelberg, Edna Schechtman, Puiu Nisipeanu 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 135 KB

PND1 INDIRECT COMPARISON OF ADVERSE EVEN

PND1 INDIRECT COMPARISON OF ADVERSE EVENTS AND DROPOUT RATES FOR EARLY PARKINSON'S DISEASE (PD) MONOTHERAPY TRIALS: PRAMIPEXOLE, ROPINIROLE AND RASAGILINE

✍ FJ Zagmutt; ML Tarrants 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Reply: Based on the available randomized

Reply: Based on the available randomized trial patients should say no to glutathione for Parkinson's disease

✍ Michael S. Okun; Anthony Lang; Joseph Jankovic 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB

We appreciate the careful reading of our manuscript by Okun and colleagues. 1 However, their letter contains a number of inaccuracies that require correction. We clearly state

Efficacy, safety, and tolerability of ov

Efficacy, safety, and tolerability of overnight switching from immediate- to once daily extended-release pramipexole in early Parkinson's disease

✍ Olivier Rascol; Paolo Barone; Robert A. Hauser; Yoshikuni Mizuno; Werner Poewe; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 1 views

## Abstract The aim of this article is to test the feasibility, in early Parkinson's disease (PD), of an overnight switch from immediate‐release (IR) pramipexole to a new once‐daily extended‐release (ER) formulation. Nonfluctuating patients on pramipexole IR three‐times daily, alone or with levodop

Patient-reported convenience of once-dai

Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson’s disease

✍ A. H. V. Schapira; P. Barone; R. A. Hauser; Y. Mizuno; O. Rascol; M. Busse; C. D 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 730 KB

626: PRECOCE and the Early Fluctuator Su

626: PRECOCE and the Early Fluctuator Survey suggest the usefulness of a new self-assessment patient card for early detection of Parkinson’s disease fluctuations

✍ Peter A. Silburn; B.I. Vieira; Gytis Danta; Lilie Herawati; J.P. Azulay; F. Duri 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 37 KB